DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 156 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $977,000 | -71.2% | 100,000 | 0.0% | 0.03% | -64.5% |
| Q3 2021 | $3,398,000 | -53.6% | 100,000 | -50.0% | 0.08% | -49.0% |
| Q2 2021 | $7,322,000 | -18.4% | 200,000 | 0.0% | 0.15% | -5.7% |
| Q1 2021 | $8,968,000 | -68.6% | 200,000 | -60.0% | 0.16% | -74.2% |
| Q4 2020 | $28,535,000 | -7.3% | 500,000 | -16.7% | 0.61% | -17.9% |
| Q3 2020 | $30,780,000 | -20.7% | 600,000 | -7.7% | 0.75% | -31.2% |
| Q2 2020 | $38,818,000 | +17.9% | 650,000 | -18.8% | 1.09% | -22.0% |
| Q1 2020 | $32,936,000 | +111.7% | 800,000 | +220.0% | 1.39% | +131.6% |
| Q4 2019 | $15,560,000 | -8.3% | 250,000 | -50.0% | 0.60% | -11.6% |
| Q3 2019 | $16,970,000 | – | 500,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |